| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.073 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |